期刊文献+

临床代谢组学的研究进展 被引量:2

Research development of clinical metabonomics
下载PDF
导出
摘要 临床代谢组学是代谢组学在临床实践中的应用,它主要研究人体不同状态下的代谢组,结合模式识别技术寻找代谢组中与疾病发生、发展、转归相关的生物标志物群,确定代谢组与健康和疾病之间的关系,从而为临床干预提供科学依据。本文主要对临床代谢组学的研究现状及存在问题做一综述。 Clinical metabonomics is the application of metabonomics in the clinical practice, and studies the metabolome at the global level, then followed by the application for pattern recognition and simultaneously to discover the biomarkers relevant to disease mechanisms, and ultimately gives support to the clinical intervention by defining the relationship of metabolome with health and disease. This review highlights the present status of clinical application of metabonomics as well as the potential challenges.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2008年第7期531-537,共7页 Chinese Journal of New Drugs and Clinical Remedies
关键词 诊断 药物监测 器官移植 生殖医学 营券学 代谢组学 diagnosis drug monitoring organ transplantation reproductive medicine nutriology metabonomics/metabolomics
  • 相关文献

参考文献7

二级参考文献119

  • 1杨军,宋硕林,Jose Castro Perez,Robert S.Plumb,许国旺.代谢组学及其应用[J].生物工程学报,2005,21(1):1-5. 被引量:52
  • 2陈晋东,赵靖平,李乐华,国效峰,吴仁容,翟金国,王传跃,谢世平,高成阁,丁瑛,陈远光.阿立哌唑治疗精神分裂症的多中心随机双盲对照试验[J].中国新药与临床杂志,2005,24(11):845-848. 被引量:65
  • 3吴晓建,李晶,刘昌孝,元英进.生物信息学应用于代谢物组学研究的进展[J].化工学报,2005,56(10):1819-1825. 被引量:10
  • 4唐惠儒,王玉兰.代谢组学:一个迅速发展的新兴学科(英文)[J].生物化学与生物物理进展,2006,33(5):401-417. 被引量:86
  • 5SERRETTI A,De RONCHI D,LORENZI C,et al.New antipsychotics and schizophrenia:a review on efficacy and side effects[J].Curr Med Chem,2004,11 (3):343-358.
  • 6DEAN B,SCARR E.Antipsychotic drugs:evolving mechanisms of action with improved therapeutic benefits[J].Curr Drug Targets CNS Neurol Disord,2004,3(3):217-225.
  • 7HOULTRAM B,SCANLAN M.Care maps:atypical antipsychotics.Introduction[J].Nurs Stand,2004,18 (36):42-44.
  • 8VOLAVKA J,CZOBOR P,SHEITMAN B,et al.Clozapine,olanzapine,risperidone,and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder[J].Am J Psychiatry,2002,159 (2):255-262.
  • 9BITTER I,DOSSENBACH MR,BROOK S,et al.Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia[J].Prog Neuropsychopharmacol Biol Psychiatry,2004,28(1):173-180.
  • 10JESTE DV,BARAK Y,MADHUSOODANAN S,et al.International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia[J].Am J Geriatr Psychiatry,2003,11 (6):638-647.

共引文献79

同被引文献27

  • 1尹崑,卫小春.关节液中多糖含量与关节软骨损伤的关系[J].实用骨科杂志,2006,12(3):216-219. 被引量:9
  • 2毛煜,袁伯俊.代谢组学的研究现状与展望[J].中国新药杂志,2007,16(13):1005-1010. 被引量:6
  • 3Hinman RS, Crossley KM. Patellofemoral joint osteoarthritis : An im- portant subgroup of knee osteoarthritis. Rheumatology ( Oxford, Eng- land) , 2007, 46 (7): 1057 -1062.
  • 4Felson DT. Osteoarthritis: new insights. Part 1 : the disease and its risk factors. Ann Intern Med, 2000, 133 (8):635 -646.
  • 5Atherton HJ, Jones OA, Malik S, et al. A comparative metabolic study of NHR - 49 in Caenorhabditis elegans and PPAR - alpha in the mouse. FEBS Letters, 2008, 582 (12):1661 -1666.
  • 6Ellis DI, Dunn WB, Griffin JL, et al. Metabolic fingerprinting as a diagnostic tool. Phammcogenomics, 2007, 8 (9): 1243 - 1266.
  • 7Weckwerth W. Metabolomics: Methods and Protocols. Totowa: Hu- manaPress Inc, 2007, Preface.
  • 8Dettmer K, Aronov PA, Hammock BD. Mass spectrometry based metabolomics. Mass Spectrom Rev, 2007, 26 (l) : 51 - 81.
  • 9Lamers RJ, van Nesselrooij JH, Kraus YB, et al. Identification of an urinary metabolite profile associated with osteoarthritis. Osteoar- thritis Cartilage, 2005, 13 (9) : 762 - 768.
  • 10LI X, Yang SB, Qiu YP, et al. Urinary metabolomics as a potential- ly novel diagnostic and stratification tool for knee osteoarthfitis. Metabolomics, 2010 (6) : 109 - 118.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部